The forecast includes around $6.4 billion in new spending comprised of additional funding for the new five year Community Pharmacy Agreement and new PBS listings. This could equate to between $1.5 and $2 billion in budgeted new spending for 2027-28. Yet the forecast is just $700 million higher than 2023-24. Something else is in there and more is coming. …
The Budget should leave people in no doubt that more announcements are coming
May 15, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The effort to change an institution from within, works best when exit is possible
October 15, 2026 - - Latest News -
The medicines gap costing Australian children time they can't get back
October 15, 2026 - - Latest News -
Brain cancer advocates return to Canberra 'to keep that ambition alive'
October 15, 2026 - - Latest News -
Priceline Pharmacy puts its name on the Diamonds as netball rides record growth
October 14, 2026 - - Latest News -
Until the law changes what the committee is instructed to weigh, these processes will deliver nothing
October 14, 2026 - - Latest News -
'Maximising off patent medicines and why the PBS needs a biosimilar strategy'
October 14, 2026 - - Latest News -
Peter Mac taps Sydney manufacturer to test its solid tumour CAR T therapy
October 14, 2026 - - Latest News